STAT3 and gastric cancer: A previous study demonstrated that STAT3 directly upregulated Toll-like receptor 2, an inflammatory mediator, to inhibit epithelial proliferation and anti-apoptosis, thereby enhancing tumorigenesis instead of inflammation in gastric cancer [177].